ImmunoGen, Inc.

AMERIPRISE FINANCIAL INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

7,619

Value ($000)

226

Weight

0.0%

2013 Q4 - 2023 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	226	0.0%	7,619	12/31/2023
2023 Q2	8/14/2023	789	0.0%	41,815	6/30/2023
2023 Q1	5/22/2023	1,102	0.0%	286,867	3/31/2023
2022 Q4	2/14/2023	1,427	0.0%	287,749	12/31/2022
2022 Q3	11/14/2022	596	0.0%	124,765	9/30/2022
2022 Q2	8/15/2022	568	0.0%	126,216	6/30/2022
2022 Q1	5/16/2022	598	0.0%	125,540	3/31/2022
2021 Q1	5/17/2021	45,324	0.0%	5,595,683	3/31/2021
2020 Q4	2/12/2021	11,981	0.0%	1,857,493	12/31/2020
2020 Q3	11/16/2020	5,104	0.0%	1,417,636	9/30/2020
2020 Q2	8/14/2020	6,612	0.0%	1,437,149	6/30/2020
2020 Q1	5/15/2020	84	0.0%	24,581	3/31/2020
2019 Q4	2/14/2020	117	0.0%	22,962	12/31/2019
2014 Q1	5/14/2014	8	0.0%	498	3/31/2014
2013 Q4	2/14/2014	13	0.0%	878	12/31/2013